Atrial Fibrillation Clinical Trials in Bangor, Maine
2 recruitingBangor, Maine
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
Phase 3
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Atrial FibrillationIntracerebral Hemorrhage
Yale University700 enrolled184 locationsNCT03907046